(1-ethylpyrrolidin-2-yl)methanamine | CAS:26116-12-1

We serve (1-ethylpyrrolidin-2-yl)methanamine CAS:26116-12-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(1-ethylpyrrolidin-2-yl)methanamine

Chemical Name:(1-ethylpyrrolidin-2-yl)methanamine
CAS.NO:26116-12-1
Synonyms:(1-ethylpyrrolidin-2-yl)methanamine
(S)-2-(Aminomethyl)-1-ethylpyrrolidine
1-Ethyl-2-(aminomethyl)pyrrolidine
2-(Aminomethyl)-1-ethylpyrrolidine
2-Pyrrolidinemethanamine,1-ethyl
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 161.9±0.0 °C at 760 mmHg
Molecular Formula C7H16N2
Molecular Weight 128.215
Flash Point 60.6±0.0 °C
 
Specification:
Appearance:Colorless to light-yellow liquid
Assay:≥99.0%
Moisture:≤2.0%
Single impurity:≤0.5%
Total impurities:≤01.0%
Unknown impurity:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Amisulpride(CAS:71675-85-9).



Contact us for information like (1-ethylpyrrolidin-2-yl)methanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyrrolidinemethanamine,1-ethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Ethyl-2-(aminomethyl)pyrrolidine Use and application,2-(Aminomethyl)-1-ethylpyrrolidine technical grade,usp/ep/jp grade.


Related News: “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.(4-methylphenyl)methyl thiocyanate manufacturer “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.3-bromo-4-fluoro-5-(trifluoromethyl)aniline supplier Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.2-Bromo-5-fluorobenzaldehyde vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.